Panacea Life Sciences Holdings Inc · OTC:PLSH
Panacea Life Sciences — Exactus — Investor Presentation (May 2019)
17 slides from Panacea Life Sciences's investor presentation, May 2, 2019
Slide 1: Hemp CBD From Seed
EXAC=US HEMP CBD FROM SEED — GENETIC SCIENCE STARTS WITH THE SEED OTCQB: EXD! May 2019
Slide 2: Cautionary Note Regarding Forward-Looking Statements
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements. Such forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets for future development and/or otherwise are not statements of historical fac
Slide 3: Defining Our Hemp Playing Field - Mission Statement
Defining Our “Hemp” Playing Field — Exactus’s Mission Statement MISSION STATEMENT * Our mission is to become the most trusted name in the CBD business. + We are intently focused on developing and providing consumers with healthy hemp derived products. We are committed to a hem future in which produc
Slide 4: Corporate Overview
CORPORATE OVERVIEW Operating Goals * Private Label and Exactus Branded Hemp-Based CBD Products * Majority Interest in 200 Acre Industrial Hemp Farm * Assisting Medical and Health-Care Professionals with Hemp Derived Education and Products + Pharmacy Sales of Hemp Derived Consumables Planned * Sponso
Slide 5: USA Hemp/CBD Market Opportunity
USA HEMP/CBD MARKET OPPORTUNITY $367M ie 2017 ~ Sales of $367M and 2018 — Hemp derived CBD The US market for Hemp represents a expected to be >$500M in 2018* outpacing other cannabis derived massive opportunity to early movers cep and innovators al ~60% The Brightfield Group estimates the total CBD
Slide 6: The Exactus Advantage
THE EXACTUS ADVANTAGE Master Development and Supply Agreement —_Exactus Products * Partnered with Ceed2Med, our largest + Full spectrum whole plant extract and isolate shareholder, for dedicated supply of biomass, used in all our products genetics, isolate/distillate for branded and white + Increasi
Slide 7: Exclusive Manufacturing and Development Partnership
EXCLUSIVE MANUFACTURING AND DEVELOPMENT PARTNERSHIP All Stages of Production to the highest cGMP, food grade standards + Ability to tack and trace every unit back to the farm + Seed to sale chain of custody + Product lability insurance ell; Multi year Master Supply and Development ‘Agreement Se Prem
Slide 8: Exactus Branded Products
Exactus Branded Products * Full spectrum whole plant extract (entourage effect from full spectrum cannabidiol oil + pure 99% crystalline cannabidiol) * Trusted quality assurance through third party lab testing & cGMP. cl for all of our CBD products ke full Hemp” = ie 4 etn Extract ot ae & % na sano
Slide 9: Production & Manufacturing
Production & Manufacturing + Planting activities have commenced, with the starting mix and seed planting in the Company's greenhouses je + Delivery of raw materials (isolate and distillate) began in = April 2019 thus launching the start of product development at two locations Farming techniques + Un
Slide 10: Seed to Sale Tracking
SEED TO SALE TRACKING Manufacturing Extraction Consumer Transportation a Cultivation @) Fibers. g " @ Harvest EXAC#US
Slide 11: Investment Highlights
INVESTMENT HIGHLIGHTS = \\\)\ Leading the development of and exceeding current oo industry standards Highest quality products on the market + Patent pending formulation technology + Patent focused cw) [Za Healthcare and professional focused, “high-end” sales call strategy + Premium pricing and margi
Slide 12: Management
MANAGEMENT JONATHAN GILBERT EXECUTIVE CHAIRMAN + Founder and CEO of Scythian Biosciences, Inc. from 2014 through May of 2018. + Seythian Biosciences, Inc. is a publicly-traded research and development company focusing ‘on the prevention and treatment of concussions and traumatic brain injury with it
Slide 13: Advisory Board
ADVISORY BOARD EMILIANO ALO! PRESIDENT & SENIOR ADVISOR + Co-founder of Ceed2Med, LLC + Vice President, Strategic Development and Director, Strategic Development, GenCanna Global ‘+ Agro-industrial Supply and Market Development Professional + Co-sponsored research programs for Stevia and Aloe Vera i
Slide 14: Board of Directors
BOARD OF DIRECTORS JOHN PRICE Independent Director + John Price currently serves as Chief Financial Officer, Treasurer and Secretary of SCWorx Corp., a publicly-traded provider of data normalization, application interoperability and big data analytics within the healthcare provider market. + Previou
Slide 15: 2019 Milestones
2019 MILESTONES Majority ownership in 200 acre industrial hemp farm & $1 million purchase order. Ql, 2019 } Ceed2Med qi, 2019 Q2, 2019 a Complete the Development and build out of the Supply Agreement commercial team. executed. E-commerce Recapitalization and platform launch. Board of Director Begin
Slide 16: Summary
SUMMARY OTCQB listed, planned NASDAQ uplisting with future public offering Executed Master Product Development and Supply ‘Agreement Full control over all aspects of the product lifecycle + Seed to final product tracking and accountability + Highest standards throughout the product lifecycle Majorit
Slide 17: Contact
EXAC#-US From The Seed To The Final Product, Only The Highest Standards. Leading The Way. Raising The Bar. For further information contact: Philip Young, Chief Executive Officer Email pyoung@exactusinc.co Andrew Johnson, Chief Strategy Officer Email ajohnson@exactusinc.co